These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 2124212

  • 1. Quinolone pharmacokinetics and metabolism.
    Lode H, Höffken G, Boeckk M, Deppermann N, Borner K, Koeppe P.
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():41-9. PubMed ID: 2124212
    [Abstract] [Full Text] [Related]

  • 2. Comparative pharmacokinetics of new quinolones.
    Lode H, Höffken G, Prinzing C, Glatzel P, Wiley R, Olschewski P, Sievers B, Reimnitz D, Borner K, Koeppe P.
    Drugs; 1987 Oct; 34 Suppl 1():21-5. PubMed ID: 3481323
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of quinolones in renal insufficiency.
    Fillastre JP, Leroy A, Moulin B, Dhib M, Borsa-Lebas F, Humbert G.
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():51-60. PubMed ID: 2124213
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of the quinolones in volunteers: a proposed dosing schedule.
    Wise R, Griggs D, Andrews JM.
    Rev Infect Dis; 1988 Oct; 10 Suppl 1():S83-9. PubMed ID: 3162327
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of fluoroquinolones in hepatic failure.
    Montay G, Gaillot J.
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():61-7. PubMed ID: 2258353
    [Abstract] [Full Text] [Related]

  • 6. [Pharmacokinetics of fluoroquinolones].
    Iakovlev VP.
    Antibiot Khimioter; 1993 Jun; 38(6):66-78. PubMed ID: 8166571
    [No Abstract] [Full Text] [Related]

  • 7. In vitro activity of enoxacin versus ciprofloxacin, fleroxacin, lomefloxacin, ofloxacin, pefloxacin, and rufloxacin against uropathogens.
    Naber KG, Well M, Hollauer K, Kirchbauer D, Witte W.
    Chemotherapy; 1998 Jun; 44(2):77-84. PubMed ID: 9551236
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of Ro 23-6240 (AM 833), a new trifluorinated quinolone.
    Weidekamm E, Stöckel K, Dell D.
    Chemioterapia; 1987 Jun; 6(2 Suppl):307-8. PubMed ID: 3151346
    [No Abstract] [Full Text] [Related]

  • 9. Steady-state kinetics of the quinolone derivatives ofloxacin, enoxacin, ciprofloxacin and pefloxacin during maintenance treatment with theophylline.
    Wijnands WJ, Vree TB, Baars AM, van Herwaarden CL.
    Drugs; 1987 Jun; 34 Suppl 1():159-69. PubMed ID: 3481317
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of ciprofloxacin.
    Bergan T, Dalhoff A, Rohwedder R.
    Infection; 1988 Jun; 16 Suppl 1():S3-13. PubMed ID: 3286512
    [Abstract] [Full Text] [Related]

  • 11. The pharmacokinetics of oral quinolones (norfloxacin, ciprofloxacin, ofloxacin).
    Alestig K.
    Scand J Infect Dis Suppl; 1990 Jun; 68():19-22. PubMed ID: 2218417
    [Abstract] [Full Text] [Related]

  • 12. Influence of renal function on the pharmacokinetics of lomefloxacin compared with other fluoroquinolones.
    Blum RA.
    Am J Med; 1992 Apr 06; 92(4A):18S-21S. PubMed ID: 1316065
    [Abstract] [Full Text] [Related]

  • 13. The comparative pharmacokinetics of five quinolones.
    Wise R, Lister D, McNulty CA, Griggs D, Andrews JM.
    J Antimicrob Chemother; 1986 Nov 06; 18 Suppl D():71-81. PubMed ID: 3468102
    [Abstract] [Full Text] [Related]

  • 14. Comparative oral pharmacokinetics of fleroxacin and pefloxacin.
    De Lepeleire I, Van Hecken A, Verbesselt R, Tjandra-Maga TB, De Schepper PJ.
    J Antimicrob Chemother; 1988 Aug 06; 22(2):197-202. PubMed ID: 3141343
    [Abstract] [Full Text] [Related]

  • 15. Active intestinal secretion of the fluoroquinolone antibacterials ciprofloxacin, norfloxacin and pefloxacin; a common secretory pathway?
    Griffiths NM, Hirst BH, Simmons NL.
    J Pharmacol Exp Ther; 1994 May 06; 269(2):496-502. PubMed ID: 8182517
    [Abstract] [Full Text] [Related]

  • 16. Penetration of ciprofloxacin, norfloxacin and ofloxacin into the aqueous humor using different topical application modes.
    Beck R, van Keyserlingk J, Fischer U, Guthoff R, Drewelow B.
    Graefes Arch Clin Exp Ophthalmol; 1999 Feb 06; 237(2):89-92. PubMed ID: 9987622
    [Abstract] [Full Text] [Related]

  • 17. Single and multiple dose pharmacokinetics of fleroxacin.
    Weidekamm E, Portmann R, Partos C, Dell D.
    J Antimicrob Chemother; 1988 Oct 06; 22 Suppl D():145-54. PubMed ID: 3144533
    [Abstract] [Full Text] [Related]

  • 18. First population pharmacokinetic analysis showing increased quinolone metabolite formation and clearance in patients with cystic fibrosis compared to healthy volunteers.
    Jiao Y, Kim TH, Tao X, Kinzig M, Landersdorfer CB, Drescher SK, Sutaria DS, Moya B, Holzgrabe U, Sörgel F, Bulitta JB.
    Eur J Pharm Sci; 2018 Oct 15; 123():416-428. PubMed ID: 30076955
    [Abstract] [Full Text] [Related]

  • 19. [Therapeutic drug monitoring of fluoroquinolone].
    Matsumoto F, Takahashi T, Morita M.
    Nihon Rinsho; 1990 Feb 15; 48 Suppl():1217-22. PubMed ID: 2355524
    [No Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of quinolones: newer aspects.
    Wolfson JS, Hooper DC.
    Eur J Clin Microbiol Infect Dis; 1991 Apr 15; 10(4):267-74. PubMed ID: 1864287
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.